1QCF image
Deposition Date 1999-05-04
Release Date 1999-06-08
Last Version Date 2024-10-09
Entry Detail
PDB ID:
1QCF
Keywords:
Title:
CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH A SRC FAMILY-SELECTIVE TYROSINE KINASE INHIBITOR
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Method Details:
Experimental Method:
Resolution:
2.00 Å
R-Value Free:
0.25
R-Value Work:
0.21
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Tyrosine-protein kinase HCK
Gene (Uniprot):HCK
Mutations:Q528E, Q529E, Q530I
Chain IDs:A
Chain Length:454
Number of Molecules:1
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
PTR A TYR modified residue
Ligand Molecules
Primary Citation
Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor.
Mol.Cell 3 639 648 (1999)
PMID: 10360180 DOI: 10.1016/S1097-2765(00)80357-3

Abstact

The crystal structure of the autoinhibited form of Hck has been determined at 2.0 A resolution, in complex with a specific pyrazolo pyrimidine-type inhibitor, PP1. The activation segment, a key regulatory component of the catalytic domain, is unphosphorylated and is visualized in its entirety. Tyr-416, the site of activating autophosphorylation in the Src family kinases, is positioned such that access to the catalytic machinery is blocked. PP1 is bound at the ATP-binding site of the kinase, and a methylphenyl group on PP1 is inserted into an adjacent hydrophobic pocket. The enlargement of this pocket in autoinhibited Src kinases suggests a route toward the development of inhibitors that are specific for the inactive forms of these proteins.

Legend

Protein

Chemical

Disease

Primary Citation of related structures